HBV Seq2 aa:28-39
HBV Seq2 aa:28-39 is a HBsAg peptide, which binds to major histocompatibility complex (MHC) class I molecules[1][2].
Product Specifications
CAS Number
168417-72-9
UNSPSC
12352209
Target
HBV
Type
Peptides
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/hbv-seq2-aa-28-39.html
Solubility
H2O
Smiles
O=C([C@H]1N(CCC1)C([C@@H](N)[C@@H](C)CC)=O)N[C@@H](CCC(N)=O)C(N[C@@H](CO)C(N[C@@H](CC(C)C)C(N[C@@H](CC(O)=O)C(N[C@@H](CO)C(N[C@@H](CC2=CNC3=CC=CC=C23)C(N[C@H](C(N[C@@H]([C@H](O)C)C(N[C@@H](CO)C(N[C@H](C(O)=O)CC(C)C)=O)=O)=O)CC4=CNC5=CC=CC=C45)=O)=O)=O)=O)=O)=O
Molecular Formula
C67H97N15O20
Molecular Weight
1432.58
References & Citations
[1]Ito H, et al. Induction of humoral and cellular immune response to HBV vaccine can be up-regulated by STING ligand. Virology. 2019 May;531:233-239. |[2]Ito H, et al. Induction of humoral and cellular immune response to hepatitis B virus (HBV) vaccine can be upregulated by CpG oligonucleotides complexed with Dectin-1 ligand. J Viral Hepat. 2017 Feb;24 (2) :155-162.
Shipping Conditions
Room temperature
Scientific Category
Peptides
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LY401671 100 µg
FAIM3 (FCMR) (NM_005449) Human Over-expression Lysate
Sign In for Pricing
View Details